Ibon Arranz-Martinez

Bizkaia Technology Park
Derio, PV, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications

Letter to the Editor: Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF).

Letter to the Editor: Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF).

Journal: Hepatology (Baltimore, Md.)
Published: June 13, 2024

One-step non-invasive diagnosis of metabolic dysfunction-associated steatohepatitis and fibrosis in high-risk population.

One-step non-invasive diagnosis of metabolic dysfunction-associated steatohepatitis and fibrosis in high-risk population.

Journal: United European gastroenterology journal
Published: February 02, 2024

Genetic algorithms applied to translational strategy in metabolic-dysfunction associated steatohepatitis (MASH). Learning from mouse models.

Genetic algorithms applied to translational strategy in metabolic-dysfunction associated steatohepatitis (MASH). Learning from mouse models.

Journal: Computer methods and programs in biomedicine
Published: May 16, 2023

Role of Intracellular Drug Disposition in the Response of Acute Myeloid Leukemia to Cytarabine and Idarubicin Induction Chemotherapy.

Role of Intracellular Drug Disposition in the Response of Acute Myeloid Leukemia to Cytarabine and Idarubicin Induction Chemotherapy.

Journal: Cancers
Published: April 28, 2023

Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF).

Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF).

Journal: Hepatology (Baltimore, Md.)
Published: July 08, 2022

Metabolic subtypes of patients with NAFLD exhibit distinctive cardiovascular risk profiles.

Metabolic subtypes of patients with NAFLD exhibit distinctive cardiovascular risk profiles.

Journal: Hepatology (Baltimore, Md.)
Published: August 11, 2021

A Novel Serum Metabolomic Profile for the Differential Diagnosis of Distal Cholangiocarcinoma and Pancreatic Ductal Adenocarcinoma.

A Novel Serum Metabolomic Profile for the Differential Diagnosis of Distal Cholangiocarcinoma and Pancreatic Ductal Adenocarcinoma.

Journal: Cancers
Published: May 07, 2020

CA19-9 capability as predictor of pancreatic cancer resectability in a Spanish cohort.

CA19-9 capability as predictor of pancreatic cancer resectability in a Spanish cohort.

Journal: Molecular biology reports
Published: October 14, 2019

Agonist of RORA Attenuates Nonalcoholic Fatty Liver Progression in Mice via Up-regulation of MicroRNA 122.

Agonist of RORA Attenuates Nonalcoholic Fatty Liver Progression in Mice via Up-regulation of MicroRNA 122.

Journal: Gastroenterology
Published: October 02, 2019

The lipidome of endometrial fluid differs between implantative and non-implantative IVF cycles.

The lipidome of endometrial fluid differs between implantative and non-implantative IVF cycles.

Journal: Journal of assisted reproduction and genetics
Published: August 29, 2019

Correction: Plasma MicroRNA Signature Validation for Early Detection of Colorectal Cancer.

Correction: Plasma MicroRNA Signature Validation for Early Detection of Colorectal Cancer.

Journal: Clinical and translational gastroenterology
Published: March 27, 2019

Plasma MicroRNA Signature Validation for Early Detection of Colorectal Cancer.

Plasma MicroRNA Signature Validation for Early Detection of Colorectal Cancer.

Journal: Clinical and translational gastroenterology
Published: February 01, 2019
Showing 1-12 of 27

Last Updated: 09/26/2026